Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States

Abstract Introduction Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI)-related hospitalizations in older adults. Without RSV-specific treatment for adults, testing is uncommon, leading to potential underestimation of RSV incidence in real-world data st...

Full description

Bibliographic Details
Main Authors: Mark H. Rozenbaum, Jen Judy, Diana Tran, Kari Yacisin, Samantha K. Kurosky, Elizabeth Begier
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-01-01
Series:Infectious Diseases and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40121-023-00758-5
_version_ 1797863983441510400
author Mark H. Rozenbaum
Jen Judy
Diana Tran
Kari Yacisin
Samantha K. Kurosky
Elizabeth Begier
author_facet Mark H. Rozenbaum
Jen Judy
Diana Tran
Kari Yacisin
Samantha K. Kurosky
Elizabeth Begier
author_sort Mark H. Rozenbaum
collection DOAJ
description Abstract Introduction Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI)-related hospitalizations in older adults. Without RSV-specific treatment for adults, testing is uncommon, leading to potential underestimation of RSV incidence in real-world data studies. This study aimed to quantify the frequency of RSV testing during LRTI-related hospitalizations of older adults to inform interpretation of incidence estimates. Methods Administrative and billing data for hospitalizations of adults aged ≥ 65 years with a primary or secondary diagnosis of LRTI during the 2016–2019 RSV seasons (October–April) were extracted from the US all-payer Premier Healthcare Database (PHD). Billing codes identified RSV tests administered during eligible hospitalizations. The proportion of LRTI-related hospitalizations with a billed RSV test was calculated for each hospital in PHD, and summarized descriptively by hospital bed size, teaching status, and population served. Results Most of the 937 study hospitals performed RSV testing infrequently during LRTI hospitalization; median percentage of LRTI hospitalizations with RSV testing was 4.3%, and 78.4% of hospitals performed RSV testing in less than 25% of LRTI-related hospitalizations. RSV testing varied extensively by hospital type. Median percentage tested was significantly higher for hospitals with ≥ 200 beds (9.1%) versus < 200 beds (1.6%), for teaching (11.0%) versus non-teaching (2.5%) hospitals, and in urban (7.4%) versus rural (0.7%) settings. The median percentage of RSV testing increased over time, from 0.8% to 6.3% between the 2016/17 and 2018/19 seasons. Conclusion A small proportion of older adults hospitalized with LRTI are tested for RSV in US hospitals. Large variability occurs across hospital types. Consequently, retrospective database analyses likely result in a substantial underestimation of the true RSV-related hospitalization incidence. RSV incidence studies using real-world data need to assess for RSV testing frequency and adjust their results for under ascertainment associated with limited testing.
first_indexed 2024-04-09T22:45:19Z
format Article
id doaj.art-dbeec84a1fbf4f78956ac36ab52796b8
institution Directory Open Access Journal
issn 2193-8229
2193-6382
language English
last_indexed 2024-04-09T22:45:19Z
publishDate 2023-01-01
publisher Adis, Springer Healthcare
record_format Article
series Infectious Diseases and Therapy
spelling doaj.art-dbeec84a1fbf4f78956ac36ab52796b82023-03-22T11:56:31ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822023-01-0112267768510.1007/s40121-023-00758-5Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United StatesMark H. Rozenbaum0Jen Judy1Diana Tran2Kari Yacisin3Samantha K. Kurosky4Elizabeth Begier5Pfizer bvPfizer IncEVERSANAPfizer VaccinesPfizer IncPfizer VaccinesAbstract Introduction Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI)-related hospitalizations in older adults. Without RSV-specific treatment for adults, testing is uncommon, leading to potential underestimation of RSV incidence in real-world data studies. This study aimed to quantify the frequency of RSV testing during LRTI-related hospitalizations of older adults to inform interpretation of incidence estimates. Methods Administrative and billing data for hospitalizations of adults aged ≥ 65 years with a primary or secondary diagnosis of LRTI during the 2016–2019 RSV seasons (October–April) were extracted from the US all-payer Premier Healthcare Database (PHD). Billing codes identified RSV tests administered during eligible hospitalizations. The proportion of LRTI-related hospitalizations with a billed RSV test was calculated for each hospital in PHD, and summarized descriptively by hospital bed size, teaching status, and population served. Results Most of the 937 study hospitals performed RSV testing infrequently during LRTI hospitalization; median percentage of LRTI hospitalizations with RSV testing was 4.3%, and 78.4% of hospitals performed RSV testing in less than 25% of LRTI-related hospitalizations. RSV testing varied extensively by hospital type. Median percentage tested was significantly higher for hospitals with ≥ 200 beds (9.1%) versus < 200 beds (1.6%), for teaching (11.0%) versus non-teaching (2.5%) hospitals, and in urban (7.4%) versus rural (0.7%) settings. The median percentage of RSV testing increased over time, from 0.8% to 6.3% between the 2016/17 and 2018/19 seasons. Conclusion A small proportion of older adults hospitalized with LRTI are tested for RSV in US hospitals. Large variability occurs across hospital types. Consequently, retrospective database analyses likely result in a substantial underestimation of the true RSV-related hospitalization incidence. RSV incidence studies using real-world data need to assess for RSV testing frequency and adjust their results for under ascertainment associated with limited testing.https://doi.org/10.1007/s40121-023-00758-5Lower respiratory tract infection (LRTI)Respiratory syncytial virus (RSV)RSV testing
spellingShingle Mark H. Rozenbaum
Jen Judy
Diana Tran
Kari Yacisin
Samantha K. Kurosky
Elizabeth Begier
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
Infectious Diseases and Therapy
Lower respiratory tract infection (LRTI)
Respiratory syncytial virus (RSV)
RSV testing
title Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
title_full Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
title_fullStr Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
title_full_unstemmed Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
title_short Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
title_sort low levels of rsv testing among adults hospitalized for lower respiratory tract infection in the united states
topic Lower respiratory tract infection (LRTI)
Respiratory syncytial virus (RSV)
RSV testing
url https://doi.org/10.1007/s40121-023-00758-5
work_keys_str_mv AT markhrozenbaum lowlevelsofrsvtestingamongadultshospitalizedforlowerrespiratorytractinfectionintheunitedstates
AT jenjudy lowlevelsofrsvtestingamongadultshospitalizedforlowerrespiratorytractinfectionintheunitedstates
AT dianatran lowlevelsofrsvtestingamongadultshospitalizedforlowerrespiratorytractinfectionintheunitedstates
AT kariyacisin lowlevelsofrsvtestingamongadultshospitalizedforlowerrespiratorytractinfectionintheunitedstates
AT samanthakkurosky lowlevelsofrsvtestingamongadultshospitalizedforlowerrespiratorytractinfectionintheunitedstates
AT elizabethbegier lowlevelsofrsvtestingamongadultshospitalizedforlowerrespiratorytractinfectionintheunitedstates